| 2, 3, 7, 8‐Tetrachlorodibenzo‐p‐dioxin (TCDD) and Related Compounds as Antioestrogens: Characterization and Mechanism of Action S Safe, B Astroff, M Harris, T Zacharewski, R Dickerson, M Romkes, ... Basic & Clinical Pharmacology & Toxicology 69 (6), 400-409, 1991 | 405 | 1991 |
| Development of a refined database of mammalian relative potency estimates for dioxin-like compounds LC Haws, SH Su, M Harris, MJ DeVito, NJ Walker, WH Farland, B Finley, ... Toxicological Sciences 89 (1), 4-30, 2005 | 182 | 2005 |
| Risk of gastrointestinal disease associated with exposure to pathogens in the water of the Lower Passaic River E Donovan, K Unice, JD Roberts, M Harris, B Finley Applied and Environmental Microbiology 74 (4), 994-1003, 2008 | 170 | 2008 |
| 2, 2′, 4, 4′, 5, 5′-Hexachlorobiphenyl as a 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin antagonist in C57BL6J mice L Biegel, M Harris, D Davis, R Rosengren, L Safe, S Safe Toxicology and applied pharmacology 97 (3), 561-571, 1989 | 168 | 1989 |
| Evaluation of impact of shale gas operations in the Barnett Shale region on volatile organic compounds in air and potential human health risks AG Bunch, CS Perry, L Abraham, DS Wikoff, JA Tachovsky, JG Hixon, ... Science of the Total Environment 468, 832-842, 2014 | 160 | 2014 |
| Effects of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin and related compounds on the occupied nuclear estrogen receptor in MCF-7 human breast cancer cells M Harris, T Zacharewski, S Safe Cancer research 50 (12), 3579-3584, 1990 | 146 | 1990 |
| A chronic oral reference dose for hexavalent chromium‐induced intestinal cancer CM Thompson, CR Kirman, DM Proctor, LC Haws, M Suh, SM Hays, ... Journal of Applied Toxicology 34 (5), 525-536, 2014 | 136 | 2014 |
| DNA-protein cross-links produced by various chemicals in cultured human lymphoma cells M Costa, A Zhitkovich, M Harris, D Paustenbach, M Gargas Journal of toxicology and environmental health 50 (5), 433-449, 1997 | 115 | 1997 |
| Evidence for the mechanism of action of the 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-mediated decrease of nuclear estrogen receptor levels in wild-type and mutant mouse Hepa … T Zacharewski, M Harris, S Safe Biochemical pharmacology 41 (12), 1931-1939, 1991 | 115 | 1991 |
| Structure-dependent induction of aryl hydrocarbon hydroxylase in human breast cancer cell lines and characterization of the Ah receptor M Harris, J Piskorska-Pliszczynska, T Zacharewski, M Romkes, S Safe Cancer research 49 (16), 4531-4535, 1989 | 109 | 1989 |
| Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans CM Thompson, DM Proctor, M Suh, LC Haws, CR Kirman, MA Harris Critical reviews in toxicology 43 (3), 244-274, 2013 | 99 | 2013 |
| Investigation of the mode of action underlying the tumorigenic response induced in B6C3F1 mice exposed orally to hexavalent chromium CM Thompson, DM Proctor, LC Haws, CD Hébert, SD Grimes, ... Toxicological Sciences 123 (1), 58-70, 2011 | 96 | 2011 |
| Application of the US EPA mode of action Framework for purposes of guiding future research: a case study involving the oral carcinogenicity of hexavalent chromium CM Thompson, LC Haws, MA Harris, NM Gatto, DM Proctor Toxicological Sciences 119 (1), 20-40, 2010 | 91 | 2010 |
| Chemometric comparisons of polychlorinated dibenzo-p-dioxin and dibenzofuran residues in surficial sediments from Newark Bay, New Jersey and other … RJ Wenning, MA Harris, MJ Ungs, DJ Paustenbach, H Bedbury Archives of Environmental Contamination and Toxicology 22 (4), 397-413, 1992 | 89 | 1992 |
| Comparative potencies of Aroclors 1232, 1242, 1248, 1254, and 1260 in male Wistar rats—assessment of the toxic equivalency factor (TEF) approach for polychlorinated biphenyls … M Harris, T Zacharewski, S Safe Toxicological Sciences 20 (4), 456-463, 1993 | 83 | 1993 |
| 6-Methyl-1, 3, 8-trichlorodibenzofuran (MCDF) is an antiestrogen in human and rodent cancer cell lines: Evidence for the role of the Ah receptor T Zachrewski, M Harris, L Biegel, V Morrison, M Merchant, S Safe Toxicology and applied pharmacology 113 (2), 311-318, 1992 | 83 | 1992 |
| Assessment of Cr (VI)-induced cytotoxicity and genotoxicity using high content analysis CM Thompson, Y Fedorov, DD Brown, M Suh, DM Proctor, L Kuriakose, ... PloS one 7 (8), e42720, 2012 | 82 | 2012 |
| Partial antagonism of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-mediated induction of aryl hydrocarbon hydroxylase by 6-methyl-1, 3, 8-trichlorodibenzofuran: mechanistic studies. M Harris, T Zacharewski, B Astroff, S Safe Molecular pharmacology 35 (5), 729-735, 1989 | 79 | 1989 |
| Comparing the Results of a Monte Carlo Analysis with EPA′ s Reasonable Maximum Exposed Individual (RMEI): A Case Study of a Former Wood Treatment Site TL Copeland, DJ Paustenbach, MA Harris, J Otani Regulatory toxicology and pharmacology 18 (2), 275-312, 1993 | 70 | 1993 |
| Evaluation of PCDD/F and dioxin-like PCB serum concentration data from the 2001–2002 National Health and Nutrition Examination Survey of the United States population LL Ferriby, JS Knutsen, M Harris, KM Unice, P Scott, P Nony, LC Haws, ... Journal of Exposure Science and Environmental Epidemiology 17 (4), 358-371, 2007 | 66 | 2007 |